large 520 kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one childhood-onset ataxias,Object
kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one of common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one of childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one,Object
kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
autosomal ataxia,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset ataxias,Object
large kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one most common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal recessive spastic ataxia,Object
kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one common childhood-onset ataxias,Object
kDa multidomain protein,Subject
autosomal ataxia,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one most common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one of childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one of childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one,Object
large 520 kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
ataxia,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset ataxias,Object
kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one of common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one of childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset ataxias,Object
large kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one most common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one,Object
large 520 kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one of common childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one,Object
large kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one most common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset ataxias,Object
large kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset ataxias,Object
kDa multidomain protein,Subject
ataxia,Object
520 kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one most common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one of childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one most common childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one of common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one,Object
large kDa multidomain protein,Subject
spastic ataxia,Object
kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset ataxias,Object
kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one of common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one most common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one,Object
kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one of common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one of childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset ataxias,Object
kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one most common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one of common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one of common childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset ataxias,Object
large kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one of childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one of childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one,Object
large kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
recessive spastic ataxia,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal spastic ataxia,Object
520 kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one most common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset ataxias,Object
kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one,Object
large 520 kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one of common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
recessive spastic ataxia,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one most common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one most common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one most common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset ataxias,Object
kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one of childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one of common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one of common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one most common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one of childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset ataxias,Object
large kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one common childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset ataxias,Object
kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one of childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset ataxias,Object
large kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset ataxias,Object
large kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one of childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset ataxias,Object
large kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset ataxias,Object
kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
autosomal ataxia,Object
large 520 kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset ataxias,Object
kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
recessive ataxia,Object
large kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
spastic ataxia,Object
kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one of common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
autosomal recessive spastic ataxia,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one of common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset ataxias,Object
kDa multidomain protein,Subject
recessive spastic ataxia,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one common childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one,Object
kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one,Object
large kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one most common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one childhood-onset ataxias,Object
large kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one of common childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
recessive ataxia,Object
520 kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
spastic ataxia,Object
kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
autosomal recessive spastic ataxia,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset ataxias,Object
large kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one of childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one of childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset ataxias,Object
kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one most common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one,Object
kDa multidomain protein,Subject
spastic ataxia,Object
large kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one most common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset ataxias,Object
kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one of childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one childhood-onset ataxias,Object
large kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one common childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one,Object
kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one,Object
520 kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one most common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one of childhood-onset ataxias,Object
kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one of common childhood-onset ataxias,Object
kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one of childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
ataxia,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one,Object
kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one most common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one of childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one,Object
large 520 kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one most common childhood-onset ataxias,Object
kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one childhood-onset ataxias,Object
large kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one of childhood-onset ataxias,Object
kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one,Object
large 520 kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one most common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one most common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one of childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one of childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one of common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
recessive ataxia,Object
large kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one common childhood-onset ataxias,Object
kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
autosomal spastic ataxia,Object
520 kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one of common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
autosomal spastic ataxia,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one,Object
kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one of common childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one,Object
520 kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset ataxias,Object
kDa multidomain protein,Subject
autosomal recessive ataxia,Object
large kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal recessive ataxia,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one,Object
520 kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one common childhood-onset ataxias,Object
kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one of common childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one,Object
large 520 kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one,Object
kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one of childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one most common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset ataxias,Object
kDa multidomain protein,Subject
autosomal recessive spastic ataxia,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset ataxias,Object
large kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one of common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one of common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal ataxia,Object
520 kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one,Object
kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one most common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
recessive spastic ataxia,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one of childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one of childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one of common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
ataxia,Object
kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one most common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one most common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one,Object
kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one,Object
kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one,Object
520 kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset ataxias,Object
kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset ataxias,Object
large kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one of childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one common childhood-onset ataxias,Object
kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one,Object
kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one of childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one of common childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset ataxias,Object
kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one of common childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset ataxias,Object
large kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one of childhood-onset ataxias,Object
large kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one of common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
recessive ataxia,Object
large kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one of common childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset ataxias,Object
kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one,Object
kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one of common childhood-onset ataxias,Object
kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one of childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
autosomal recessive ataxia,Object
520 kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one most common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one,Object
large 520 kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one most common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one childhood-onset ataxias,Object
large kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one of common childhood-onset ataxias,Object
kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one most common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one of childhood-onset ataxias,Object
kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
autosomal spastic ataxia,Object
large 520 kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one of childhood-onset ataxias,Object
large kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset ataxias,Object
kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one most common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one common childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one of childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one of common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one common childhood-onset ataxias,Object
kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one of common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one,Object
large kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one of common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one,Object
large kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one childhood-onset ataxias,Object
large kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one most common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one most common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one of childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one common childhood-onset ataxias,Object
kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one,Object
520 kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one,Object
large kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one,Object
large 520 kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one childhood-onset ataxias,Object
kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset ataxias,Object
large kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one childhood-onset ataxias,Object
large kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
autosomal recessive ataxia,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one,Object
kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one,Object
large kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one most common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
recessive ataxia of Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
autosomal recessive ataxia of Charlevoix-Saguenay one childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one of common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset ataxias,Object
kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
spastic ataxia of Charlevoix-Saguenay one of common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
large 520 kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one most common childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
autosomal recessive spastic ataxia of Charlevoix-Saguenay one common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one childhood-onset ataxias,Object
kDa multidomain protein,Subject
recessive spastic ataxia of Charlevoix-Saguenay one childhood-onset ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset recessive ataxias,Object
kDa multidomain protein,Subject
Charlevoix-Saguenay one of most common childhood-onset ataxias,Object
520 kDa multidomain protein,Subject
autosomal spastic ataxia of Charlevoix-Saguenay one of childhood-onset recessive ataxias,Object
large kDa multidomain protein,Subject
Charlevoix-Saguenay one,Object
520 kDa multidomain protein,Subject
ataxia of Charlevoix-Saguenay one common childhood-onset ataxias,Object
large kDa multidomain protein,Subject
autosomal ataxia of Charlevoix-Saguenay one childhood-onset recessive ataxias,Object
520 kDa multidomain protein,Subject
Charlevoix-Saguenay one common childhood-onset ataxias,Object
prominent feature,Subject
many neuronal populations,Object
feature,Subject
many neuronal populations,Object
prominent feature,Subject
neuronal populations,Object
prominent feature,Subject
abnormal,Object
feature,Subject
abnormal,Object
feature,Subject
neuronal populations,Object
study,Subject
domains,Object
study,Subject
important domains,Object
Peptides,Subject
ubiquitin-like domain modified neurofilament assembly,Object
Peptides,Subject
ubiquitin-like domain neurofilament assembly,Object
Peptides,Subject
sacsin internal repeat 1 J-domains,Object
Peptides,Subject
domain neurofilament assembly,Object
Peptides,Subject
domain modified neurofilament assembly,Object
Peptides,Subject
sacsin repeat 1 J-domains,Object
J-domain,Subject
opposite effects,Object
effects,Subject
filament assembly,Object
SIRPT,Subject
effects,Object
J-domain,Subject
effects,Object
SIRPT,Subject
chaperone homology,Object
SIRPT,Subject
opposite effects,Object
SIRPT,Subject
opposite effects,Object
domains,Subject
opposite effects,Object
domains,Subject
effects,Object
domains,Subject
opposite effects,Object
domains,Subject
chaperone homology,Object
SIRPT,Subject
effects,Object
J-domain,Subject
effects,Object
J-domain,Subject
chaperone homology,Object
domains,Subject
effects,Object
domains,Subject
chaperone homology,Object
SIRPT,Subject
chaperone homology,Object
J-domain,Subject
opposite effects,Object
opposite effects,Subject
filament assembly,Object
J-domain,Subject
chaperone homology,Object
Recent studies,Subject
increasing incidence,Object
studies,Subject
incidence,Object
Recent studies,Subject
increasing incidence of cutaneous carcinomas,Object
studies,Subject
incidence of adnexal carcinomas,Object
Recent studies,Subject
incidence,Object
Recent studies,Subject
years,Object
Recent studies,Subject
years,Object
Recent studies,Subject
incidence of adnexal carcinomas,Object
studies,Subject
incidence of cutaneous carcinomas,Object
Recent studies,Subject
increasing incidence of cutaneous adnexal carcinomas,Object
studies,Subject
incidence of cutaneous adnexal carcinomas,Object
studies,Subject
incidence of carcinomas,Object
Recent studies,Subject
incidence of carcinomas,Object
studies,Subject
increasing incidence of cutaneous carcinomas,Object
studies,Subject
years,Object
Recent studies,Subject
incidence of cutaneous adnexal carcinomas,Object
studies,Subject
increasing incidence of carcinomas,Object
studies,Subject
increasing incidence of adnexal carcinomas,Object
studies,Subject
increasing incidence of cutaneous adnexal carcinomas,Object
Recent studies,Subject
increasing incidence of carcinomas,Object
Recent studies,Subject
incidence of cutaneous carcinomas,Object
studies,Subject
years,Object
studies,Subject
increasing incidence,Object
Recent studies,Subject
increasing incidence of adnexal carcinomas,Object
antineutrophil cytoplasmic vasculitis,Subject
syndrome,Object
antineutrophil cytoplasmic antibody-associated vasculitis,Subject
syndrome,Object
inflammatory disorder,Subject
mixed presentation,Object
antineutrophil vasculitis,Subject
syndrome,Object
lupus erythematosus,Subject
syndrome,Object
vasculitis,Subject
syndrome,Object
cytoplasmic antibody-associated vasculitis,Subject
syndrome,Object
antibody-associated vasculitis,Subject
syndrome,Object
Systemic lupus erythematosus,Subject
syndrome,Object
cytoplasmic vasculitis,Subject
syndrome,Object
antineutrophil antibody-associated vasculitis,Subject
syndrome,Object
renal disease,Subject
organ system,Object
disease,Subject
organ system,Object
disease,Subject
body,Object
renal disease,Subject
body,Object
syndrome,Subject
patients,Object
Neurologic manifestation,Subject
patients with SLE-AAV,Object
manifestation,Subject
syndrome,Object
patients,Subject
SLE-AAV,Object
syndrome,Subject
patients with SLE-AAV,Object
syndrome,Subject
patients,Object
syndrome,Subject
patients with SLE-AAV,Object
Neurologic manifestation,Subject
syndrome,Object
patient,Subject
SLE-AAV,Object
patient,Subject
SAH,Object
overlap syndrome,Subject
intracranial aneurysm,Object
overlap syndrome,Subject
patient,Object
overlap syndrome,Subject
patient with SAH,Object
overlap syndrome,Subject
aneurysm,Object
Neurologic involvement,Subject
syndrome,Object
syndrome,Subject
patients,Object
patients,Subject
SLE-AAV,Object
syndrome,Subject
patients with SLE-AAV,Object
Neurologic involvement,Subject
patients with SLE-AAV,Object
syndrome,Subject
patients with SLE-AAV,Object
involvement,Subject
syndrome,Object
syndrome,Subject
patients,Object
present,Subject
association between SLE-AAV,Object
patients,Subject
neurologic signs,Object
present,Subject
association,Object
present,Subject
SLE-AAV,Object
skull,Subject
relatively rare benign tumors,Object
skull,Subject
benign tumors,Object
skull,Subject
relatively rare benign tumors,Object
malformations,Subject
relatively rare benign tumors,Object
skull,Subject
relatively rare benign tumors,Object
Intraosseous malformations,Subject
rare tumors,Object
skull,Subject
tumors,Object
cavernous malformations,Subject
relatively rare tumors,Object
cavernous malformations,Subject
rare tumors,Object
Intraosseous cavernous malformations,Subject
relatively rare tumors,Object
malformations,Subject
rare tumors,Object
skull,Subject
rare benign tumors,Object
Intraosseous cavernous malformations,Subject
benign tumors,Object
skull,Subject
benign tumors,Object
Intraosseous malformations,Subject
relatively rare tumors,Object
Intraosseous malformations,Subject
tumors,Object
Intraosseous cavernous malformations,Subject
relatively rare benign tumors,Object
cavernous malformations,Subject
benign tumors,Object
skull,Subject
rare benign tumors,Object
skull,Subject
relatively rare tumors,Object
Intraosseous cavernous malformations,Subject
rare benign tumors,Object
skull,Subject
tumors,Object
Intraosseous cavernous malformations,Subject
rare tumors,Object
skull,Subject
tumors,Object
skull,Subject
tumors,Object
skull,Subject
rare tumors,Object
Intraosseous malformations,Subject
relatively rare benign tumors,Object
skull,Subject
rare tumors,Object
Intraosseous cavernous malformations,Subject
tumors,Object
skull,Subject
relatively rare tumors,Object
skull,Subject
relatively rare tumors,Object
cavernous malformations,Subject
relatively rare benign tumors,Object
malformations,Subject
tumors,Object
Intraosseous malformations,Subject
rare benign tumors,Object
cavernous malformations,Subject
rare benign tumors,Object
malformations,Subject
benign tumors,Object
malformations,Subject
rare benign tumors,Object
skull,Subject
rare benign tumors,Object
skull,Subject
rare tumors,Object
malformations,Subject
relatively rare tumors,Object
skull,Subject
rare tumors,Object
skull,Subject
rare benign tumors,Object
skull,Subject
benign tumors,Object
skull,Subject
ICMs,Object
Intraosseous malformations,Subject
benign tumors,Object
cavernous malformations,Subject
tumors,Object
skull,Subject
relatively rare tumors,Object
skull,Subject
benign tumors,Object
skull,Subject
relatively rare benign tumors,Object
Knowledge,Subject
poor,Object
goals,Subject
manifestations,Object
goals,Subject
manifestations of disease,Object
goals,Subject
clinical manifestations,Object
goals,Subject
clinical manifestations of disease,Object
We,Subject
analysis,Object
We,Subject
retrospective analysis,Object
incidence,Subject
1.15 % among entire series of intracranial CMs,Object
incidence,Subject
1.15 % among series,Object
incidence,Subject
1.15 % among series of intracranial CMs,Object
incidence,Subject
1.15 % among entire series,Object
incidence,Subject
1.15 %,Object
incidence,Subject
1.15 % among entire series of CMs,Object
incidence,Subject
1.15 % among series of CMs,Object
their mean age,Subject
38.7 years,Object
manifestation,Subject
swelling,Object
commonest manifestation,Subject
swelling,Object
manifestation,Subject
swelling,Object
commonest clinical manifestation,Subject
swelling,Object
clinical manifestation,Subject
swelling,Object
commonest clinical manifestation,Subject
swelling,Object
clinical manifestation,Subject
swelling,Object
commonest manifestation,Subject
swelling,Object
Complete lesion resection,Subject
achieved,Object
achieved,Subject
performed,Object
achieved,Subject
titanium mesh,Object
achieved,Subject
11 cases,Object
lesion resection,Subject
achieved,Object
symptom,Subject
discharge,Object
Postoperative complication,Subject
found,Object
complication,Subject
found,Object
symptom,Subject
discharge,Object
mean follow-up period,Subject
76.2 months,Object
mean period,Subject
76.2 months,Object
patient,Subject
petroclival ICM,Object
differential diagnosis,Subject
case of,Object
it,Subject
should always considered as diagnosis in case of,Object
it,Subject
should always considered as diagnosis,Object
it,Subject
should always considered as differential diagnosis in case,Object
it,Subject
should considered as diagnosis,Object
it,Subject
should considered as differential diagnosis,Object
it,Subject
should considered as differential diagnosis in case,Object
it,Subject
should always considered as diagnosis in case,Object
ICM,Subject
rare,Object
it,Subject
should always considered,Object
it,Subject
should considered,Object
it,Subject
should always considered as differential diagnosis in case of,Object
cranial ICM,Subject
rare,Object
it,Subject
should always considered as differential diagnosis,Object
it,Subject
should considered as differential diagnosis in case of,Object
it,Subject
should considered as diagnosis in case of,Object
it,Subject
should considered as diagnosis in case,Object
Surgical resection,Subject
should treatment of choice for patients,Object
Surgical resection,Subject
should treatment,Object
Surgical resection,Subject
should treatment of choice for symptomatic patients,Object
Surgical resection,Subject
should treatment of choice,Object
Surgical resection,Subject
should treatment for patients,Object
Surgical resection,Subject
should treatment for symptomatic patients,Object
pseudorheumatoid dysplasia,Subject
bone disorder,Object
pseudorheumatoid dysplasia,Subject
genetic bone disorder,Object
pseudorheumatoid dysplasia,Subject
bone disorder characterised,Object
Progressive pseudorheumatoid dysplasia,Subject
genetic bone disorder,Object
pseudorheumatoid dysplasia,Subject
genetic bone disorder characterised,Object
Progressive pseudorheumatoid dysplasia,Subject
bone disorder,Object
Progressive pseudorheumatoid dysplasia,Subject
bone disorder characterised,Object
Progressive pseudorheumatoid dysplasia,Subject
genetic bone disorder characterised,Object
dysplasia,Subject
genetic,Object
PPRD,Subject
rare,Object
radiological features,Subject
PPRD,Object
radiological features,Subject
PPRD,Object
features,Subject
PPRD,Object
features,Subject
PPRD,Object
Our aim,Subject
literature,Object
PPRD,Subject
mutation,Object
PPRD,Subject
mutation in signalling protein 3,Object
mutation,Subject
Wnt1-inducible signalling protein 3,Object
PPRD,Subject
due,Object
PPRD,Subject
mutation in Wnt1-inducible signalling protein 3,Object
signalling factor,Subject
cartilage homeostasis,Object
disease onset,Subject
time leading,Object
disease onset,Subject
time leading to disability,Object
disease onset,Subject
childhood changes,Object
disease onset,Subject
time leading to significant disability,Object
disease onset,Subject
time,Object
child,Subject
systemic inflammation,Object
PPRD,Subject
rare,Object
PPRD,Subject
should suspected,Object
child,Subject
symmetrical involvement,Object
child,Subject
symmetrical polyarticular involvement,Object
PPRD,Subject
should suspected,Object
child,Subject
involvement,Object
child,Subject
polyarticular involvement,Object
child,Subject
inflammation,Object
Genetic testing,Subject
study of genomic DNA,Object
testing,Subject
study,Object
WISP3,Subject
can only detected,Object
testing,Subject
study of DNA extracted,Object
Genetic testing,Subject
study,Object
Genetic testing,Subject
study of genomic DNA extracted,Object
WISP3,Subject
splicing aberrations,Object
testing,Subject
study of genomic DNA extracted,Object
testing,Subject
study of genomic DNA,Object
testing,Subject
study of DNA,Object
Genetic testing,Subject
study of DNA,Object
Genetic testing,Subject
study of DNA extracted,Object
WISP3,Subject
can detected,Object
patients,Subject
typical PPRD findings,Object
skin biopsy,Subject
patients with typical PPRD findings,Object
skin biopsy,Subject
patients with PPRD findings,Object
skin biopsy,Subject
patients with PPRD findings,Object
skin biopsy,Subject
therefore indicated,Object
skin biopsy,Subject
indicated,Object
skin biopsy,Subject
patients,Object
skin biopsy,Subject
patients with typical PPRD findings,Object
skin biopsy,Subject
patients,Object
Megapouch,Subject
restorative proctocolectomy,Object
Megapouch,Subject
restorative proctocolectomy,Object
Megapouch,Subject
complication of proctocolectomy with ileal pouch-anal anastomosis,Object
Megapouch,Subject
rare functional complication of restorative proctocolectomy with pouch-anal anastomosis,Object
Megapouch,Subject
complication,Object
Megapouch,Subject
ileal anastomosis,Object
Megapouch,Subject
complication of restorative proctocolectomy with anastomosis,Object
Megapouch,Subject
ileal pouch-anal anastomosis,Object
Megapouch,Subject
complication of proctocolectomy with ileal anastomosis,Object
Megapouch,Subject
rare functional complication of restorative proctocolectomy with ileal pouch-anal anastomosis,Object
Megapouch,Subject
rare functional complication of proctocolectomy with anastomosis,Object
Megapouch,Subject
functional complication of restorative proctocolectomy with ileal anastomosis,Object
Megapouch,Subject
rare functional complication of proctocolectomy with ileal anastomosis,Object
Megapouch,Subject
rare complication of restorative proctocolectomy with anastomosis,Object
Megapouch,Subject
functional complication of restorative proctocolectomy with anastomosis,Object
Megapouch,Subject
proctocolectomy,Object
Megapouch,Subject
ileal pouch-anal anastomosis,Object
Megapouch,Subject
rare functional complication of restorative proctocolectomy with anastomosis,Object
Megapouch,Subject
rare complication,Object
Megapouch,Subject
rare functional complication,Object
Megapouch,Subject
pouch-anal anastomosis,Object
Megapouch,Subject
proctocolectomy,Object
Megapouch,Subject
ileal anastomosis,Object
Megapouch,Subject
rare complication of proctocolectomy with pouch-anal anastomosis,Object
Megapouch,Subject
functional complication of proctocolectomy with pouch-anal anastomosis,Object
Megapouch,Subject
anastomosis,Object
Megapouch,Subject
anastomosis,Object
Megapouch,Subject
functional complication of restorative proctocolectomy with ileal pouch-anal anastomosis,Object
Megapouch,Subject
rare complication of proctocolectomy with ileal anastomosis,Object
Megapouch,Subject
rare,Object
Megapouch,Subject
rare complication of restorative proctocolectomy with ileal pouch-anal anastomosis,Object
Megapouch,Subject
functional complication,Object
Megapouch,Subject
rare functional complication of proctocolectomy with ileal pouch-anal anastomosis,Object
Megapouch,Subject
pouch-anal anastomosis,Object
Megapouch,Subject
ileal pouch-anal anastomosis,Object
Megapouch,Subject
complication of restorative proctocolectomy with pouch-anal anastomosis,Object
Megapouch,Subject
anastomosis,Object
Megapouch,Subject
ileal anastomosis,Object
Megapouch,Subject
functional complication of proctocolectomy with anastomosis,Object
Megapouch,Subject
complication of restorative proctocolectomy with ileal anastomosis,Object
Megapouch,Subject
restorative proctocolectomy,Object
Megapouch,Subject
functional complication of proctocolectomy with ileal anastomosis,Object
Megapouch,Subject
proctocolectomy,Object
Megapouch,Subject
rare functional complication of proctocolectomy with pouch-anal anastomosis,Object
Megapouch,Subject
anastomosis,Object
Megapouch,Subject
rare complication of proctocolectomy with ileal pouch-anal anastomosis,Object
Megapouch,Subject
rare complication of restorative proctocolectomy with ileal anastomosis,Object
Megapouch,Subject
rare functional complication of restorative proctocolectomy with ileal anastomosis,Object
Megapouch,Subject
proctocolectomy,Object
Megapouch,Subject
restorative proctocolectomy,Object
Megapouch,Subject
ileal pouch-anal anastomosis,Object
Megapouch,Subject
rare complication of restorative proctocolectomy with pouch-anal anastomosis,Object
Megapouch,Subject
ileal anastomosis,Object
Megapouch,Subject
functional complication of restorative proctocolectomy with pouch-anal anastomosis,Object
Megapouch,Subject
pouch-anal anastomosis,Object
rare functional complication,Subject
ileal pouch-anal anastomosis characterized by pouch ± small bowel dilatation,Object
Megapouch,Subject
functional complication of proctocolectomy with ileal pouch-anal anastomosis,Object
Megapouch,Subject
functional,Object
Megapouch,Subject
complication of proctocolectomy with anastomosis,Object
Megapouch,Subject
complication of proctocolectomy with pouch-anal anastomosis,Object
Megapouch,Subject
pouch-anal anastomosis,Object
Megapouch,Subject
rare complication of proctocolectomy with anastomosis,Object
Megapouch,Subject
complication of restorative proctocolectomy with ileal pouch-anal anastomosis,Object
Little,Subject
clinical characteristics of entity,Object
Little,Subject
characteristics,Object
Little,Subject
characteristics of entity,Object
Little,Subject
clinical characteristics,Object
Little,Subject
known,Object
tumors,Subject
cord,Object
Concurrent multiple tumors,Subject
cord,Object
Concurrent tumors,Subject
spinal cord,Object
tumors,Subject
spinal cord,Object
multiple tumors,Subject
spinal cord,Object
multiple tumors,Subject
cord,Object
Concurrent multiple tumors,Subject
spinal cord,Object
Concurrent tumors,Subject
cord,Object
tumors,Subject
level with discrete histopathology,Object
tumors,Subject
level,Object
tumors,Subject
same level with histopathology,Object
concurrent tumors,Subject
spinal level with histopathology,Object
same spinal level,Subject
discrete histopathology,Object
tumors,Subject
much rarer,Object
tumors,Subject
same spinal level with discrete histopathology,Object
tumors,Subject
spinal level,Object
concurrent tumors,Subject
spinal level with discrete histopathology,Object
concurrent tumors,Subject
level,Object
concurrent tumors,Subject
same level with histopathology,Object
tumors,Subject
rarer,Object
tumors,Subject
spinal level with histopathology,Object
concurrent tumors,Subject
level with discrete histopathology,Object
concurrent tumors,Subject
same spinal level with histopathology,Object
tumors,Subject
same spinal level with histopathology,Object
tumors,Subject
same spinal level,Object
tumors,Subject
level with histopathology,Object
concurrent tumors,Subject
spinal level,Object
concurrent tumors,Subject
same spinal level with discrete histopathology,Object
concurrent tumors,Subject
much rarer,Object
tumors,Subject
same level with discrete histopathology,Object
concurrent tumors,Subject
rarer,Object
concurrent tumors,Subject
same level,Object
concurrent tumors,Subject
same level with discrete histopathology,Object
concurrent tumors,Subject
level with histopathology,Object
concurrent tumors,Subject
same spinal level,Object
tumors,Subject
spinal level with discrete histopathology,Object
tumors,Subject
same level,Object
We,Subject
two cases,Object
We,Subject
two such cases,Object
Magnetic resonance angiography,Subject
severe stenosis of terminal portion of bilateral carotid arteries,Object
Magnetic resonance angiography,Subject
severe stenosis of terminal portion of carotid arteries,Object
resonance angiography,Subject
stenosis of terminal portion,Object
Magnetic resonance angiography,Subject
severe stenosis of portion of carotid arteries,Object
resonance angiography,Subject
stenosis of portion of carotid arteries,Object
resonance angiography,Subject
severe stenosis of portion,Object
resonance angiography,Subject
stenosis of terminal portion of internal carotid arteries,Object
Magnetic resonance angiography,Subject
severe stenosis of terminal portion of internal carotid arteries,Object
Magnetic resonance angiography,Subject
stenosis of terminal portion of internal carotid arteries,Object
resonance angiography,Subject
severe stenosis of terminal portion of carotid arteries,Object
Magnetic resonance angiography,Subject
stenosis of portion of carotid arteries,Object
Magnetic resonance angiography,Subject
severe stenosis,Object
Magnetic resonance angiography,Subject
stenosis of terminal portion of bilateral carotid arteries,Object
resonance angiography,Subject
severe stenosis,Object
resonance angiography,Subject
stenosis of portion of bilateral internal carotid arteries,Object
resonance angiography,Subject
stenosis of terminal portion of bilateral internal carotid arteries,Object
Magnetic resonance angiography,Subject
stenosis,Object
Magnetic resonance angiography,Subject
severe stenosis of portion of bilateral internal carotid arteries,Object
resonance angiography,Subject
stenosis of terminal portion of carotid arteries,Object
Magnetic resonance angiography,Subject
stenosis of portion,Object
resonance angiography,Subject
severe stenosis of terminal portion,Object
Magnetic resonance angiography,Subject
severe stenosis of portion of bilateral carotid arteries,Object
resonance angiography,Subject
severe stenosis of portion of carotid arteries,Object
resonance angiography,Subject
severe stenosis of portion of bilateral internal carotid arteries,Object
Magnetic resonance angiography,Subject
stenosis of portion of bilateral carotid arteries,Object
Magnetic resonance angiography,Subject
stenosis of portion of internal carotid arteries,Object
Magnetic resonance angiography,Subject
severe stenosis of portion,Object
resonance angiography,Subject
stenosis of portion,Object
resonance angiography,Subject
severe stenosis of terminal portion of bilateral carotid arteries,Object
Magnetic resonance angiography,Subject
severe stenosis of terminal portion of bilateral internal carotid arteries,Object
resonance angiography,Subject
severe stenosis of terminal portion of bilateral internal carotid arteries,Object
resonance angiography,Subject
severe stenosis of portion of bilateral carotid arteries,Object
resonance angiography,Subject
stenosis,Object
Magnetic resonance angiography,Subject
stenosis of terminal portion,Object
resonance angiography,Subject
severe stenosis of portion of internal carotid arteries,Object
Magnetic resonance angiography,Subject
severe stenosis of portion of internal carotid arteries,Object
resonance angiography,Subject
severe stenosis of terminal portion of internal carotid arteries,Object
resonance angiography,Subject
stenosis of portion of internal carotid arteries,Object
Magnetic resonance angiography,Subject
stenosis of terminal portion of carotid arteries,Object
resonance angiography,Subject
stenosis of terminal portion of bilateral carotid arteries,Object
resonance angiography,Subject
stenosis of portion of bilateral carotid arteries,Object
Magnetic resonance angiography,Subject
severe stenosis of terminal portion,Object
Magnetic resonance angiography,Subject
stenosis of terminal portion of bilateral internal carotid arteries,Object
Magnetic resonance angiography,Subject
stenosis of portion of bilateral internal carotid arteries,Object
Cranial MR images,Subject
hematoma in basal ganglia perforating,Object
MR images,Subject
hematoma,Object
MR images,Subject
hematoma in ganglia,Object
Cranial MR images,Subject
hematoma in left ganglia perforating,Object
MR images,Subject
hematoma in left basal ganglia perforating,Object
Cranial MR images,Subject
hematoma,Object
Cranial MR images,Subject
hematoma in ganglia,Object
MR images,Subject
hematoma in basal ganglia,Object
Cranial MR images,Subject
hematoma in left ganglia,Object
MR images,Subject
hematoma in basal ganglia perforating,Object
MR images,Subject
hematoma in left ganglia perforating,Object
MR images,Subject
hematoma in left basal ganglia,Object
Cranial MR images,Subject
hematoma in basal ganglia,Object
MR images,Subject
hematoma perforating,Object
hematoma,Subject
left basal ganglia,Object
Cranial MR images,Subject
hematoma in left basal ganglia,Object
MR images,Subject
hematoma in ganglia perforating,Object
MR images,Subject
hematoma in left ganglia,Object
Cranial MR images,Subject
hematoma perforating,Object
Cranial MR images,Subject
hematoma in left basal ganglia perforating,Object
Cranial MR images,Subject
hematoma in ganglia perforating,Object
patient,Subject
conservative management,Object
patient,Subject
cerebral hemorrhage,Object
patient,Subject
hemorrhage,Object
patient,Subject
removal,Object
patient,Subject
total removal of tumor,Object
patient,Subject
management,Object
patient,Subject
removal of tumor,Object
patient,Subject
removal of spinal tumor,Object
patient,Subject
total removal of spinal tumor,Object
patient,Subject
total removal,Object
tumor,Subject
components,Object
tumor,Subject
extra components,Object
extra components,Subject
schwannoma respectively,Object
components,Subject
schwannoma,Object
extra components,Subject
schwannoma,Object
components,Subject
schwannoma respectively,Object
Craniocervical MR images,Subject
tumor,Object
Craniocervical MR images,Subject
paraspinal tumor,Object
MR images,Subject
paraspinal tumor,Object
MR images,Subject
tumor,Object
tumor,Subject
major extradural,Object
tumor,Subject
extradural,Object
extradural lesion,Subject
meningioma,Object
components,Subject
histological findings,Object
lesion,Subject
meningioma,Object
components,Subject
discrete findings,Object
components,Subject
findings,Object
components,Subject
discrete histological findings,Object
tumors,Subject
should considered in tumors,Object
they,Subject
particularly when located,Object
tumors,Subject
should considered in tumors with extra components,Object
they,Subject
high cervical spine,Object
tumors,Subject
should considered,Object
they,Subject
high spine,Object
they,Subject
when located in spine,Object
Concurrent tumors,Subject
should considered in tumors,Object
they,Subject
when located in high cervical spine,Object
Concurrent tumors,Subject
discrete histopathology,Object
they,Subject
when located in high spine,Object
they,Subject
particularly located,Object
tumors,Subject
should considered in tumors with components,Object
Concurrent tumors,Subject
should considered,Object
they,Subject
particularly when located in high cervical spine,Object
they,Subject
when located in cervical spine,Object
they,Subject
spine,Object
they,Subject
high spine,Object
they,Subject
cervical spine,Object
they,Subject
high cervical spine,Object
they,Subject
particularly when located in high spine,Object
Concurrent tumors,Subject
should considered in tumors with components,Object
they,Subject
spine,Object
they,Subject
when located,Object
they,Subject
located,Object
tumors,Subject
extra components,Object
Concurrent tumors,Subject
should considered in tumors with extra components,Object
they,Subject
particularly when located in cervical spine,Object
they,Subject
cervical spine,Object
they,Subject
particularly when located in spine,Object
Acute retinitis,Subject
has considered,Object
Acute multifocal retinitis,Subject
has considered,Object
multifocal retinitis,Subject
has considered,Object
retinitis,Subject
has considered,Object
Acute retinitis,Subject
has considered,Object
multifocal retinitis,Subject
has considered,Object
Acute multifocal retinitis,Subject
has considered,Object
retinitis,Subject
rare,Object
retinitis,Subject
has considered,Object
purpose,Subject
causes,Object
causes,Subject
acute multifocal retinitis,Object
purpose,Subject
clinical features of multifocal retinitis,Object
causes,Subject
multifocal retinitis,Object
purpose,Subject
features of retinitis,Object
purpose,Subject
features of multifocal retinitis,Object
purpose,Subject
clinical features of retinitis,Object
causes,Subject
retinitis,Object
purpose,Subject
features,Object
purpose,Subject
clinical features of acute retinitis,Object
causes,Subject
acute retinitis,Object
purpose,Subject
clinical features of acute multifocal retinitis,Object
purpose,Subject
features of acute retinitis,Object
causes,Subject
acute multifocal retinitis,Object
purpose,Subject
features of acute multifocal retinitis,Object
causes,Subject
acute retinitis,Object
causes,Subject
retinitis,Object
causes,Subject
multifocal retinitis,Object
purpose,Subject
clinical features,Object
Uveal melanoma,Subject
common adult intraocular cancer,Object
Uveal melanoma,Subject
adult intraocular cancer,Object
melanoma,Subject
most common adult primary cancer,Object
Uveal melanoma,Subject
most common adult primary cancer,Object
Uveal melanoma,Subject
most common primary intraocular cancer,Object
melanoma,Subject
common intraocular cancer,Object
melanoma,Subject
adult primary intraocular cancer,Object
melanoma,Subject
common cancer,Object
melanoma,Subject
common adult intraocular cancer,Object
Uveal melanoma,Subject
common primary intraocular cancer,Object
melanoma,Subject
most common primary cancer,Object
melanoma,Subject
common adult primary cancer,Object
melanoma,Subject
most common cancer,Object
melanoma,Subject
most common adult cancer,Object
Uveal melanoma,Subject
common cancer,Object
Uveal melanoma,Subject
most common cancer,Object
Uveal melanoma,Subject
most common adult cancer,Object
Uveal melanoma,Subject
intraocular cancer,Object
melanoma,Subject
most common adult primary intraocular cancer,Object
Uveal melanoma,Subject
common adult primary cancer,Object
Uveal melanoma,Subject
common intraocular cancer,Object
melanoma,Subject
adult cancer,Object
melanoma,Subject
common primary intraocular cancer,Object
Uveal melanoma,Subject
most common primary cancer,Object
Uveal melanoma,Subject
most common adult intraocular cancer,Object
melanoma,Subject
adult intraocular cancer,Object
Uveal melanoma,Subject
primary intraocular cancer,Object
melanoma,Subject
primary intraocular cancer,Object
melanoma,Subject
most common primary intraocular cancer,Object
melanoma,Subject
adult primary cancer,Object
Uveal melanoma,Subject
common adult cancer,Object
melanoma,Subject
cancer,Object
melanoma,Subject
primary cancer,Object
Uveal melanoma,Subject
cancer,Object
Uveal melanoma,Subject
most common intraocular cancer,Object
Uveal melanoma,Subject
adult cancer,Object
melanoma,Subject
common adult cancer,Object
melanoma,Subject
intraocular cancer,Object
melanoma,Subject
common primary cancer,Object
Uveal melanoma,Subject
adult primary cancer,Object
Uveal melanoma,Subject
common adult primary intraocular cancer,Object
Uveal melanoma,Subject
most common adult primary intraocular cancer,Object
melanoma,Subject
most common intraocular cancer,Object
Uveal melanoma,Subject
primary cancer,Object
melanoma,Subject
common adult primary intraocular cancer,Object
Uveal melanoma,Subject
adult primary intraocular cancer,Object
melanoma,Subject
most common adult intraocular cancer,Object
Uveal melanoma,Subject
common primary cancer,Object
liver metastasis,Subject
common to natural history of disease metastasis to eye,Object
liver metastasis,Subject
fellow eye,Object
liver metastasis,Subject
common to history to eye,Object
liver metastasis,Subject
common,Object
liver metastasis,Subject
history of disease metastasis,Object
liver metastasis,Subject
natural history of disease metastasis,Object
common,Subject
extremely rare,Object
liver metastasis,Subject
eye,Object
liver metastasis,Subject
common to natural history to fellow eye,Object
liver metastasis,Subject
common to history of disease metastasis to eye,Object
liver metastasis,Subject
natural history,Object
liver metastasis,Subject
common to natural history of disease metastasis to fellow eye,Object
liver metastasis,Subject
history,Object
liver metastasis,Subject
common to natural history to eye,Object
liver metastasis,Subject
common to history of disease metastasis to fellow eye,Object
liver metastasis,Subject
common to history to fellow eye,Object
common,Subject
rare,Object
we,Subject
case,Object
we,Subject
case,Object
59-year-old man,Subject
choroidal melanoma,Object
59-year-old man,Subject
his right eye,Object
patient,Subject
referred,Object
patient,Subject
21 months postoperatively complaining of vision,Object
patient,Subject
complaining,Object
patient,Subject
our service,Object
patient,Subject
21 months postoperatively complaining of decreased vision,Object
patient,Subject
vision,Object
patient,Subject
21 months postoperatively complaining,Object
patient,Subject
decreased vision,Object
patient,Subject
postoperatively complaining,Object
patient,Subject
complaining of decreased vision,Object
patient,Subject
complaining of vision,Object
patient,Subject
postoperatively complaining of decreased vision,Object
patient,Subject
decreased vision,Object
patient,Subject
vision,Object
patient,Subject
postoperatively complaining of vision,Object
He,Subject
new pigmented tumor,Object
He,Subject
his eye associated with liver disease,Object
He,Subject
pigmented tumor,Object
He,Subject
pigmented choroidal tumor,Object
He,Subject
new tumor,Object
He,Subject
found,Object
He,Subject
his eye,Object
He,Subject
choroidal tumor,Object
He,Subject
his eye associated,Object
He,Subject
new choroidal tumor,Object
He,Subject
his left eye,Object
He,Subject
tumor,Object
He,Subject
his left eye associated with liver disease,Object
He,Subject
new pigmented choroidal tumor,Object
He,Subject
his left eye associated,Object
ultrasonography,Subject
performed,Object
ultrasonography,Subject
histopathological analysis,Object
liver biopsy,Subject
diagnosis,Object
Ocular ultrasonography,Subject
performed,Object
similar cases,Subject
have described,Object
Few similar cases,Subject
have described in literature,Object
similar cases,Subject
have described in literature,Object
Few similar cases,Subject
have described,Object
differential diagnosis,Subject
choroidal tumor,Object
diagnosis,Subject
bilateral choroidal melanoma,Object
differential diagnosis,Subject
primary melanoma from primary skin melanoma,Object
diagnosis,Subject
bilateral choroidal melanoma from skin melanoma,Object
diagnosis,Subject
melanoma from primary skin melanoma,Object
differential diagnosis,Subject
primary melanoma,Object
diagnosis,Subject
primary bilateral choroidal melanoma,Object
diagnosis,Subject
choroidal tumor,Object
differential diagnosis,Subject
melanoma from skin melanoma,Object
diagnosis,Subject
bilateral melanoma from primary skin melanoma,Object
differential diagnosis,Subject
tumor,Object
differential diagnosis,Subject
choroidal melanoma,Object
diagnosis,Subject
primary melanoma from skin melanoma,Object
differential diagnosis,Subject
choroidal melanoma from skin melanoma,Object
diagnosis,Subject
choroidal melanoma from skin melanoma,Object
diagnosis,Subject
metastatic choroidal tumor,Object
differential diagnosis,Subject
primary melanoma from skin melanoma,Object
differential diagnosis,Subject
melanoma,Object
differential diagnosis,Subject
bilateral choroidal melanoma from primary skin melanoma,Object
diagnosis,Subject
primary choroidal melanoma from primary skin melanoma,Object
diagnosis,Subject
tumor,Object
differential diagnosis,Subject
bilateral melanoma from primary skin melanoma,Object
differential diagnosis,Subject
metastatic choroidal tumor,Object
differential diagnosis,Subject
primary bilateral choroidal melanoma from skin melanoma,Object
differential diagnosis,Subject
metastatic tumor,Object
differential diagnosis,Subject
primary choroidal melanoma from primary skin melanoma,Object
differential diagnosis,Subject
primary choroidal melanoma from skin melanoma,Object
diagnosis,Subject
bilateral choroidal melanoma from primary skin melanoma,Object
diagnosis,Subject
choroidal melanoma,Object
differential diagnosis,Subject
melanoma from primary skin melanoma,Object
differential diagnosis,Subject
primary bilateral melanoma from skin melanoma,Object
diagnosis,Subject
primary bilateral melanoma from skin melanoma,Object
differential diagnosis,Subject
primary bilateral melanoma,Object
diagnosis,Subject
metastatic tumor,Object
diagnosis,Subject
primary choroidal melanoma,Object
differential diagnosis,Subject
bilateral melanoma,Object
diagnosis,Subject
primary bilateral melanoma,Object
differential diagnosis,Subject
primary bilateral melanoma from primary skin melanoma,Object
diagnosis,Subject
melanoma,Object
diagnosis,Subject
primary melanoma,Object
diagnosis,Subject
primary bilateral choroidal melanoma from primary skin melanoma,Object
diagnosis,Subject
primary bilateral choroidal melanoma from skin melanoma,Object
differential diagnosis,Subject
choroidal melanoma from primary skin melanoma,Object
differential diagnosis,Subject
primary bilateral choroidal melanoma,Object
diagnosis,Subject
primary melanoma from primary skin melanoma,Object
differential diagnosis,Subject
bilateral choroidal melanoma,Object
differential diagnosis,Subject
bilateral choroidal melanoma from skin melanoma,Object
differential diagnosis,Subject
bilateral melanoma from skin melanoma,Object
differential diagnosis,Subject
primary choroidal melanoma,Object
diagnosis,Subject
primary choroidal melanoma from skin melanoma,Object
differential diagnosis,Subject
primary bilateral choroidal melanoma from primary skin melanoma,Object
diagnosis,Subject
primary bilateral melanoma from primary skin melanoma,Object
diagnosis,Subject
bilateral melanoma from skin melanoma,Object
diagnosis,Subject
melanoma from skin melanoma,Object
diagnosis,Subject
choroidal melanoma from primary skin melanoma,Object
diagnosis,Subject
bilateral melanoma,Object
Adamantinomas,Subject
bone tumors,Object
Adamantinomas,Subject
rare bone tumors,Object
bone tumors,Subject
tibia,Object
rare bone tumors,Subject
tibia,Object
rare bone tumors,Subject
tibia,Object
bone tumors,Subject
tibia,Object
purpose,Subject
outcomes of patients with adamantinoma,Object
purpose,Subject
outcomes of patients treated,Object
purpose,Subject
outcomes of patients treated in institution,Object
purpose,Subject
outcomes of patients with adamantinoma treated,Object
purpose,Subject
outcomes of patients with adamantinoma treated in single institution,Object
purpose,Subject
outcomes of patients with adamantinoma treated in institution,Object
purpose,Subject
outcomes of patients treated in single institution,Object
purpose,Subject
outcomes of patients,Object
patients,Subject
adamantinoma,Object
purpose,Subject
outcomes,Object
diabetes,Subject
acromegaly,Object
Cushing,Subject
disease,Object
few detailed studies,Subject
focus on cardiovascular risk,Object
diabetes,Subject
common,Object
diabetes,Subject
complication,Object
diabetes,Subject
common complication,Object
diabetes,Subject
acromegaly,Object
we,Subject
characterization from DPV,Object
we,Subject
characterization from longitudinal DPV,Object
we,Subject
characterization from longitudinal DPV,Object
we,Subject
characterization from DPV,Object
we,Subject
characterization,Object
we,Subject
characterization,Object
we,Subject
comprehensive characterization from DPV,Object
we,Subject
comprehensive characterization,Object
we,Subject
comprehensive characterization from longitudinal DPV,Object
we,Subject
comprehensive characterization from longitudinal DPV,Object
we,Subject
comprehensive characterization,Object
we,Subject
comprehensive characterization from DPV,Object
sepsis surgery,Subject
changes,Object
sepsis surgery,Subject
major changes,Object
sepsis cardiac surgery,Subject
changes,Object
sepsis surgery,Subject
major changes in leukocyte subsets,Object
major changes,Subject
leukocyte subsets,Object
sepsis cardiac surgery,Subject
cardiopulmonary bypass,Object
sepsis cardiac surgery,Subject
major changes,Object
sepsis surgery,Subject
changes in leukocyte subsets,Object
sepsis cardiac surgery,Subject
changes in leukocyte subsets,Object
sepsis cardiac surgery,Subject
major changes in leukocyte subsets,Object
granulocytes,Subject
sepsis,Object
Immature granulocytes,Subject
open-heart surgery,Object
granulocytes,Subject
surgery,Object
granulocytes,Subject
open-heart surgery,Object
Immature granulocytes,Subject
sepsis,Object
Immature granulocytes,Subject
surgery,Object
infections,Subject
surgery,Object
Secondary infections,Subject
major complication,Object
Secondary infections,Subject
cardiac surgery,Object
infections,Subject
surgery with CPB,Object
infections,Subject
complication,Object
infections,Subject
cardiac surgery with CPB,Object
Secondary infections,Subject
cardiac surgery,Object
Secondary infections,Subject
cardiac surgery with CPB,Object
infections,Subject
cardiac surgery,Object
infections,Subject
cardiac surgery with CPB,Object
Secondary infections,Subject
complication,Object
infections,Subject
major,Object
infections,Subject
surgery with CPB,Object
Secondary infections,Subject
surgery,Object
infections,Subject
major complication,Object
Secondary infections,Subject
cardiac surgery with CPB,Object
infections,Subject
surgery,Object
cardiac surgery,Subject
CPB,Object
infections,Subject
cardiac surgery,Object
Secondary infections,Subject
surgery with CPB,Object
Secondary infections,Subject
surgery with CPB,Object
Secondary infections,Subject
surgery,Object
front-line clinician,Subject
multicolor flow cytometry,Object
front-line clinician,Subject
patients at risk of complications,Object
clinician,Subject
patients at risk of complications,Object
front-line clinician,Subject
setting,Object
clinician,Subject
setting,Object
clinician,Subject
patients at risk,Object
clinician,Subject
patients at risk of infectious complications,Object
clinician,Subject
clinical setting,Object
clinician,Subject
patients at high risk of complications,Object
clinician,Subject
patients at high risk,Object
front-line clinician,Subject
setting,Object
front-line clinician,Subject
patients at risk,Object
assessment,Subject
multicolor flow cytometry,Object
clinician,Subject
patients at high risk of infectious complications,Object
clinician,Subject
multicolor flow cytometry,Object
clinician,Subject
clinical setting,Object
clinician,Subject
patients,Object
front-line clinician,Subject
clinical setting,Object
front-line clinician,Subject
patients,Object
front-line clinician,Subject
patients at risk,Object
clinician,Subject
FCM,Object
front-line clinician,Subject
patients at high risk of infectious complications,Object
clinician,Subject
patients,Object
front-line clinician,Subject
FCM,Object
front-line clinician,Subject
patients at risk of complications,Object
clinician,Subject
leukocyte subsets,Object
clinician,Subject
patients at high risk of complications,Object
front-line clinician,Subject
patients at high risk of infectious complications,Object
front-line clinician,Subject
patients,Object
front-line clinician,Subject
patients at risk of infectious complications,Object
clinician,Subject
patients at high risk,Object
clinician,Subject
patients at risk of complications,Object
front-line clinician,Subject
patients at high risk of complications,Object
clinician,Subject
patients at risk of infectious complications,Object
assessment,Subject
clinician,Object
front-line clinician,Subject
patients at high risk,Object
front-line clinician,Subject
clinical setting,Object
clinician,Subject
patients at high risk of infectious complications,Object
assessment,Subject
front-line clinician,Object
front-line clinician,Subject
patients at high risk,Object
clinician,Subject
setting,Object
front-line clinician,Subject
leukocyte subsets,Object
front-line clinician,Subject
patients at high risk of complications,Object
front-line clinician,Subject
patients at risk of infectious complications,Object
clinician,Subject
patients at risk,Object
sclerosis,Subject
connective tissue disease,Object
complex auto-immune tissue disease,Subject
inflammatory manifestations,Object
tissue disease,Subject
vasculopathic manifestations,Object
auto-immune connective tissue disease,Subject
vasculopathic manifestations,Object
sclerosis,Subject
complex tissue disease,Object
complex auto-immune tissue disease,Subject
manifestations,Object
Systemic sclerosis,Subject
complex auto-immune connective tissue disease,Object
Systemic sclerosis,Subject
tissue disease,Object
sclerosis,Subject
auto-immune connective tissue disease,Object
tissue disease,Subject
inflammatory manifestations,Object
complex tissue disease,Subject
vasculopathic manifestations,Object
complex auto-immune tissue disease,Subject
vasculopathic manifestations,Object
complex connective tissue disease,Subject
inflammatory manifestations,Object
Systemic sclerosis,Subject
complex auto-immune tissue disease,Object
sclerosis,Subject
connective,Object
auto-immune tissue disease,Subject
vasculopathic manifestations,Object
connective tissue disease,Subject
vasculopathic manifestations,Object
tissue disease,Subject
inflammatory vasculopathic manifestations,Object
sclerosis,Subject
auto-immune tissue disease,Object
complex connective tissue disease,Subject
vasculopathic manifestations,Object
connective tissue disease,Subject
inflammatory vasculopathic manifestations,Object
Systemic sclerosis,Subject
connective tissue disease,Object
tissue disease,Subject
manifestations,Object
complex tissue disease,Subject
manifestations,Object
complex auto-immune connective tissue disease,Subject
inflammatory manifestations,Object
sclerosis,Subject
tissue disease,Object
auto-immune connective tissue disease,Subject
manifestations,Object
auto-immune tissue disease,Subject
inflammatory vasculopathic manifestations,Object
sclerosis,Subject
auto-immune,Object
complex tissue disease,Subject
inflammatory vasculopathic manifestations,Object
Systemic sclerosis,Subject
complex tissue disease,Object
sclerosis,Subject
complex connective tissue disease,Object
complex tissue disease,Subject
inflammatory manifestations,Object
auto-immune tissue disease,Subject
inflammatory manifestations,Object
Systemic sclerosis,Subject
complex connective tissue disease,Object
complex auto-immune connective tissue disease,Subject
manifestations,Object
sclerosis,Subject
complex auto-immune tissue disease,Object
complex connective tissue disease,Subject
inflammatory vasculopathic manifestations,Object
complex auto-immune tissue disease,Subject
inflammatory vasculopathic manifestations,Object
sclerosis,Subject
complex auto-immune connective tissue disease,Object
complex connective tissue disease,Subject
manifestations,Object
connective tissue disease,Subject
inflammatory manifestations,Object
complex auto-immune connective tissue disease,Subject
vasculopathic manifestations,Object
Systemic sclerosis,Subject
auto-immune connective tissue disease,Object
auto-immune connective tissue disease,Subject
inflammatory vasculopathic manifestations,Object
connective tissue disease,Subject
manifestations,Object
Systemic sclerosis,Subject
auto-immune tissue disease,Object
complex auto-immune connective tissue disease,Subject
inflammatory vasculopathic manifestations,Object
auto-immune connective tissue disease,Subject
inflammatory manifestations,Object
sclerosis,Subject
complex,Object
auto-immune tissue disease,Subject
manifestations,Object
CCN proteins,Subject
proteins,Object
CCN proteins,Subject
matricellular proteins implicated in major cellular processes,Object
CCN proteins,Subject
matricellular proteins implicated,Object
CCN proteins,Subject
secreted proteins implicated in major processes,Object
CCN proteins,Subject
proteins implicated in cellular processes,Object
CCN proteins,Subject
secreted matricellular proteins implicated,Object
CCN proteins,Subject
matricellular proteins implicated in major processes,Object
CCN proteins,Subject
proteins implicated,Object
CCN proteins,Subject
proteins implicated in major processes,Object
CCN proteins,Subject
proteins implicated in processes,Object
CCN proteins,Subject
matricellular proteins implicated in cellular processes,Object
CCN proteins,Subject
proteins implicated in major cellular processes,Object
CCN proteins,Subject
secreted matricellular proteins implicated in major cellular processes,Object
CCN proteins,Subject
matricellular proteins,Object
CCN proteins,Subject
secreted matricellular proteins implicated in processes,Object
CCN proteins,Subject
secreted proteins implicated in cellular processes,Object
CCN proteins,Subject
family,Object
CCN proteins,Subject
secreted matricellular proteins implicated in cellular processes,Object
CCN proteins,Subject
secreted proteins implicated,Object
CCN proteins,Subject
secreted matricellular proteins implicated in major processes,Object
CCN proteins,Subject
secreted matricellular proteins,Object
CCN proteins,Subject
secreted proteins,Object
CCN proteins,Subject
secreted proteins implicated in major cellular processes,Object
CCN proteins,Subject
secreted proteins implicated in processes,Object
CCN proteins,Subject
matricellular proteins implicated in processes,Object
They,Subject
have already implicated in key processes of SSc,Object
They,Subject
have already implicated in pathophysiological processes of SSc,Object
They,Subject
have implicated in key pathophysiological processes of SSc,Object
They,Subject
have implicated in key pathophysiological processes,Object
They,Subject
have already implicated in key pathophysiological processes,Object
They,Subject
have implicated in pathophysiological processes of SSc,Object
They,Subject
have already implicated in processes of SSc,Object
They,Subject
have implicated in key processes of SSc,Object
They,Subject
have implicated in key processes,Object
They,Subject
have already implicated,Object
They,Subject
have already implicated in pathophysiological processes,Object
They,Subject
have implicated,Object
They,Subject
have already implicated in processes,Object
They,Subject
have implicated in processes,Object
They,Subject
have implicated in processes of SSc,Object
They,Subject
have implicated in pathophysiological processes,Object
They,Subject
have already implicated in key pathophysiological processes of SSc,Object
They,Subject
have already implicated in key processes,Object
we,Subject
possible implication in SSc pathogenesis with focus on skin features,Object
we,Subject
possible implication of CCN proteins in SSc pathogenesis with special focus on skin features,Object
we,Subject
potential CCN targets,Object
we,Subject
possible implication,Object
we,Subject
possible implication of CCN proteins in SSc pathogenesis with focus on skin features,Object
we,Subject
potential actionable CCN targets,Object
we,Subject
possible implication in SSc pathogenesis with focus,Object
we,Subject
possible implication of CCN proteins in SSc pathogenesis with special focus,Object
we,Subject
possible implication in SSc pathogenesis with special focus on skin features,Object
SSc pathogenesis,Subject
special focus on skin features,Object
we,Subject
possible implication of CCN proteins,Object
we,Subject
possible implication in SSc pathogenesis with special focus,Object
possible implication,Subject
SSc pathogenesis with special focus on skin features,Object
we,Subject
possible implication of CCN proteins in SSc pathogenesis with focus,Object
we,Subject
possible implication in SSc pathogenesis,Object
we,Subject
possible implication of CCN proteins in SSc pathogenesis,Object
article,Subject
protected,Object
article,Subject
copyright,Object
Trichothiodystrophy,Subject
group of diseases characterized by DNA repair anomalies,Object
Trichothiodystrophy,Subject
group of genetic diseases,Object
Trichothiodystrophy,Subject
group of diseases characterized,Object
Trichothiodystrophy,Subject
group of rare genetic diseases characterized,Object
Trichothiodystrophy,Subject
group of rare diseases characterized,Object
Trichothiodystrophy,Subject
group of rare diseases characterized by DNA repair anomalies,Object
Trichothiodystrophy,Subject
group of genetic diseases characterized,Object
Trichothiodystrophy,Subject
group of rare diseases,Object
Trichothiodystrophy,Subject
group of genetic diseases characterized by DNA repair anomalies,Object
Trichothiodystrophy,Subject
group of rare genetic diseases characterized by DNA repair anomalies,Object
Trichothiodystrophy,Subject
group of rare genetic diseases,Object
Trichothiodystrophy,Subject
group of diseases,Object
Trichothiodystrophy,Subject
group,Object
Ocular manifestations,Subject
50 % of cases including cataract errors,Object
manifestations,Subject
50 %,Object
Ocular manifestations,Subject
50 % of cases including cataract refractive errors,Object
manifestations,Subject
50 % of cases including cataract refractive errors,Object
manifestations,Subject
50 % of cases,Object
Ocular manifestations,Subject
50 %,Object
manifestations,Subject
50 % of cases including cataract errors,Object
Ocular manifestations,Subject
50 % of cases,Object
patient,Subject
trichothiodystrophy,Object
We,Subject
case of childhood glaucoma,Object
case,Subject
patient with trichothiodystrophy,Object
We,Subject
case,Object
Endometrial cancer,Subject
United States,Object
cancer,Subject
United States,Object
Endometrial cancer,Subject
United States,Object
Endometrial cancer,Subject
United States,Object
cancer,Subject
diagnosed gynecologic malignancy,Object
Endometrial cancer,Subject
commonly diagnosed malignancy,Object
Endometrial cancer,Subject
United States,Object
Endometrial cancer,Subject
United States,Object
cancer,Subject
commonly diagnosed malignancy,Object
Endometrial cancer,Subject
United States,Object
diagnosed gynecologic malignancy,Subject
United States,Object
Endometrial cancer,Subject
diagnosed gynecologic malignancy,Object
Endometrial cancer,Subject
malignancy,Object
cancer,Subject
commonly diagnosed gynecologic malignancy,Object
cancer,Subject
United States,Object
Endometrial cancer,Subject
United States,Object
cancer,Subject
United States,Object
cancer,Subject
diagnosed malignancy,Object
cancer,Subject
most commonly diagnosed gynecologic malignancy,Object
cancer,Subject
United States,Object
Endometrial cancer,Subject
diagnosed malignancy,Object
cancer,Subject
gynecologic malignancy,Object
Endometrial cancer,Subject
commonly diagnosed gynecologic malignancy,Object
cancer,Subject
United States,Object
cancer,Subject
most commonly diagnosed malignancy,Object
Endometrial cancer,Subject
gynecologic malignancy,Object
Endometrial cancer,Subject
most commonly diagnosed malignancy,Object
Endometrial cancer,Subject
most commonly diagnosed gynecologic malignancy,Object
Endometrial cancer,Subject
United States,Object
cancer,Subject
United States,Object
cancer,Subject
United States,Object
cancer,Subject
malignancy,Object
cancer,Subject
United States,Object
carcinomas,Subject
approximately 3-10 %,Object
carcinosarcomas,Subject
tumors,Object
carcinomas,Subject
approximately 3-10 % of diagnoses,Object
carcinosarcomas,Subject
rare biphasic tumors,Object
carcinosarcomas,Subject
rare tumors,Object
serous carcinomas,Subject
approximately 3-10 % of diagnoses,Object
serous carcinomas,Subject
approximately 3-10 %,Object
uterine carcinosarcomas,Subject
rare tumors,Object
uterine carcinosarcomas,Subject
rare biphasic tumors,Object
uterine carcinosarcomas,Subject
biphasic tumors,Object
carcinosarcomas,Subject
biphasic tumors,Object
uterine carcinosarcomas,Subject
tumors,Object
observations,Subject
driver,Object
observations,Subject
driver of carcinomas,Object
Longstanding observations,Subject
drivers of clear cell carcinomas,Object
observations,Subject
driver of endometrioid carcinomas,Object
molecular observations,Subject
drivers,Object
observations,Subject
drivers of cell carcinomas,Object
observations,Subject
drivers,Object
Longstanding observations,Subject
drivers of cell carcinomas,Object
Longstanding observations,Subject
drivers,Object
observations,Subject
major driver of endometrioid carcinomas,Object
Longstanding observations,Subject
gene,Object
Longstanding molecular observations,Subject
gene,Object
Longstanding molecular observations,Subject
drivers of cell carcinomas,Object
molecular observations,Subject
gene,Object
Longstanding molecular observations,Subject
drivers,Object
observations,Subject
major driver of carcinomas,Object
molecular observations,Subject
drivers of cell carcinomas,Object
observations,Subject
PTEN inactivation,Object
observations,Subject
gene,Object
observations,Subject
major driver,Object
molecular observations,Subject
drivers of clear cell carcinomas,Object
observations,Subject
drivers of clear cell carcinomas,Object
Longstanding molecular observations,Subject
drivers of clear cell carcinomas,Object
exome sequencing,Subject
pathogenic aberrations in histotype,Object
exome sequencing,Subject
additional pathogenic aberrations in histotype,Object
additional pathogenic aberrations,Subject
histotype,Object
exome sequencing,Subject
additional aberrations in histotype,Object
targeted gene,Subject
aberrations in histotype,Object
gene,Subject
pathogenic aberrations in histotype,Object
targeted gene,Subject
pathogenic aberrations in histotype,Object
targeted gene,Subject
additional aberrations in histotype,Object
gene,Subject
additional pathogenic aberrations in histotype,Object
gene,Subject
additional aberrations in histotype,Object
exome sequencing,Subject
aberrations in histotype,Object
gene,Subject
aberrations in histotype,Object
targeted gene,Subject
additional pathogenic aberrations in histotype,Object
analysis,Subject
classification of endometrioid into four subgroups POLE,Object
analysis,Subject
classification of endometrioid into four distinct subgroups POLE,Object
analysis,Subject
molecular classification into four distinct subgroups POLE,Object
analysis,Subject
classification into four subgroups POLE,Object
analysis,Subject
classification,Object
analysis,Subject
classification of endometrioid into four subgroups POLE,Object
analysis,Subject
molecular classification,Object
analysis,Subject
classification of endometrioid into four distinct subgroups POLE,Object
analysis,Subject
classification into four distinct subgroups POLE,Object
analysis,Subject
molecular classification into four subgroups POLE,Object
analysis,Subject
classification of endometrioid,Object
analysis,Subject
molecular classification into four distinct subgroups POLE,Object
analysis,Subject
classification into four subgroups POLE,Object
analysis,Subject
molecular classification,Object
analysis,Subject
classification,Object
analysis,Subject
classification into four distinct subgroups POLE,Object
analysis,Subject
molecular classification into four subgroups POLE,Object
analysis,Subject
classification of endometrioid,Object
we,Subject
potential implications for carcinoma,Object
we,Subject
overview of features of aforementioned subtypes,Object
we,Subject
overview,Object
discuss,Subject
carcinoma,Object
we,Subject
overview of features of aforementioned histopathological subtypes,Object
we,Subject
review,Object
we,Subject
overview of features of subtypes,Object
we,Subject
potential implications,Object
we,Subject
overview of features of histopathological subtypes,Object
we,Subject
potential prognostic implications for endometrial carcinoma,Object
discuss,Subject
endometrial carcinoma,Object
we,Subject
potential implications for endometrial carcinoma,Object
we,Subject
overview of features,Object
discuss,Subject
carcinoma,Object
discuss,Subject
endometrial carcinoma,Object
we,Subject
potential prognostic implications,Object
discuss,Subject
endometrial carcinoma,Object
we,Subject
potential prognostic implications for carcinoma,Object
discuss,Subject
carcinoma,Object
right atrium,Subject
very rare abnormality,Object
enlargement,Subject
rare,Object
atrium,Subject
abnormality,Object
Idiopathic enlargement,Subject
very rare abnormality,Object
right atrium,Subject
rare abnormality,Object
atrium,Subject
very rare abnormality,Object
right atrium,Subject
very rare abnormality,Object
enlargement,Subject
rare abnormality,Object
enlargement,Subject
very rare abnormality,Object
right atrium,Subject
rare abnormality,Object
Idiopathic enlargement,Subject
rare abnormality,Object
Idiopathic enlargement,Subject
abnormality,Object
enlargement,Subject
abnormality,Object
right atrium,Subject
abnormality,Object
atrium,Subject
rare abnormality,Object
right atrium,Subject
abnormality,Object
atrium,Subject
rare abnormality,Object
atrium,Subject
abnormality,Object
atrium,Subject
very rare abnormality,Object
patients,Subject
48 %,Object
symptoms,Subject
shortness palpitations arrhythmias,Object
symptoms,Subject
rare cases,Object
symptoms,Subject
shortness of breath palpitations arrhythmias,Object
symptoms,Subject
cases,Object
symptoms,Subject
12 %,Object
We,Subject
one such case of man with disproportionally enlarged right atrium,Object
We,Subject
one case of young man with disproportionally enlarged atrium,Object
We,Subject
one such case of man with atrium,Object
We,Subject
one such case of young man with atrium,Object
We,Subject
one case of man with enlarged atrium,Object
We,Subject
one case of young man with enlarged right atrium,Object
We,Subject
one such case of man,Object
We,Subject
one such case of young man with enlarged right atrium,Object
We,Subject
one case of young man with disproportionally enlarged right atrium,Object
We,Subject
one such case of young man with disproportionally enlarged atrium,Object
We,Subject
one case of young man with enlarged atrium,Object
We,Subject
one case of man with right atrium,Object
We,Subject
one case of young man with atrium,Object
We,Subject
one case of man with atrium,Object
We,Subject
one case of man with enlarged right atrium,Object
We,Subject
one such case,Object
We,Subject
one such case of young man with enlarged atrium,Object
We,Subject
one such case of man with enlarged right atrium,Object
We,Subject
one case of man,Object
We,Subject
one case of young man,Object
We,Subject
one case of man with disproportionally enlarged right atrium,Object
We,Subject
one case,Object
We,Subject
one case of young man with right atrium,Object
We,Subject
one case of man with disproportionally enlarged atrium,Object
We,Subject
one such case of man with disproportionally enlarged atrium,Object
We,Subject
one such case of man with enlarged atrium,Object
We,Subject
one such case of man with right atrium,Object
We,Subject
one such case of young man with right atrium,Object
young man,Subject
disproportionally enlarged right atrium,Object
We,Subject
one such case of young man with disproportionally enlarged right atrium,Object
We,Subject
one such case of young man,Object
echocardiogram,Subject
huge right atrium,Object
echocardiogram,Subject
right atrium with thick smoke pattern,Object
basal transthoracic echocardiogram,Subject
huge right atrium with thick smoke pattern in absence of heart disease,Object
basal echocardiogram,Subject
right atrium with smoke pattern in absence,Object
basal echocardiogram,Subject
huge right atrium with thick smoke pattern,Object
echocardiogram,Subject
huge right atrium with thick smoke pattern in absence of congenital heart disease,Object
basal echocardiogram,Subject
huge right atrium in absence,Object
basal echocardiogram,Subject
huge right atrium with smoke pattern in absence,Object
basal echocardiogram,Subject
huge right atrium,Object
echocardiogram,Subject
huge right atrium in absence,Object
transthoracic echocardiogram,Subject
huge right atrium,Object
basal transthoracic echocardiogram,Subject
huge right atrium with thick smoke pattern in absence of congenital heart disease,Object
basal transthoracic echocardiogram,Subject
right atrium in absence of heart disease,Object
echocardiogram,Subject
right atrium with thick smoke pattern in absence,Object
transthoracic echocardiogram,Subject
huge right atrium with smoke pattern in absence,Object
transthoracic echocardiogram,Subject
huge right atrium with thick smoke pattern in absence of congenital heart disease,Object
basal echocardiogram,Subject
right atrium with thick smoke pattern,Object
transthoracic echocardiogram,Subject
right atrium with thick smoke pattern in absence,Object
basal transthoracic echocardiogram,Subject
right atrium in absence of congenital heart disease,Object
basal transthoracic echocardiogram,Subject
right atrium with smoke pattern in absence of congenital heart disease,Object
echocardiogram,Subject
right atrium with thick smoke pattern in absence of congenital heart disease,Object
transthoracic echocardiogram,Subject
right atrium in absence of heart disease,Object
echocardiogram,Subject
huge right atrium in absence of heart disease,Object
basal echocardiogram,Subject
huge right atrium in absence of heart disease,Object
echocardiogram,Subject
right atrium with smoke pattern in absence of heart disease,Object
huge right atrium,Subject
thick smoke pattern,Object
basal transthoracic echocardiogram,Subject
huge right atrium with smoke pattern,Object
basal transthoracic echocardiogram,Subject
right atrium with thick smoke pattern in absence of heart disease,Object
echocardiogram,Subject
right atrium with smoke pattern in absence,Object
echocardiogram,Subject
huge right atrium with thick smoke pattern in absence,Object
basal transthoracic echocardiogram,Subject
right atrium with smoke pattern in absence,Object
basal transthoracic echocardiogram,Subject
huge right atrium with thick smoke pattern in absence,Object
transthoracic echocardiogram,Subject
right atrium with smoke pattern in absence of heart disease,Object
basal transthoracic echocardiogram,Subject
right atrium in absence,Object
echocardiogram,Subject
right atrium in absence,Object
transthoracic echocardiogram,Subject
huge right atrium in absence of congenital heart disease,Object
basal echocardiogram,Subject
right atrium with thick smoke pattern in absence of heart disease,Object
transthoracic echocardiogram,Subject
huge right atrium in absence,Object
basal echocardiogram,Subject
right atrium,Object
basal echocardiogram,Subject
right atrium in absence of congenital heart disease,Object
echocardiogram,Subject
right atrium with thick smoke pattern in absence of heart disease,Object
basal transthoracic echocardiogram,Subject
huge right atrium in absence of congenital heart disease,Object
transthoracic echocardiogram,Subject
huge right atrium with smoke pattern in absence of congenital heart disease,Object
transthoracic echocardiogram,Subject
huge right atrium with thick smoke pattern,Object
echocardiogram,Subject
huge right atrium with thick smoke pattern in absence of heart disease,Object
transthoracic echocardiogram,Subject
huge right atrium with smoke pattern in absence of heart disease,Object
echocardiogram,Subject
huge right atrium with smoke pattern,Object
basal echocardiogram,Subject
huge right atrium with smoke pattern in absence of congenital heart disease,Object
basal echocardiogram,Subject
huge right atrium with thick smoke pattern in absence of heart disease,Object
transthoracic echocardiogram,Subject
huge right atrium with thick smoke pattern in absence of heart disease,Object
echocardiogram,Subject
huge right atrium with smoke pattern in absence of heart disease,Object
transthoracic echocardiogram,Subject
right atrium with thick smoke pattern,Object
basal echocardiogram,Subject
huge right atrium in absence of congenital heart disease,Object
basal transthoracic echocardiogram,Subject
huge right atrium with smoke pattern in absence,Object
basal echocardiogram,Subject
right atrium in absence,Object
transthoracic echocardiogram,Subject
huge right atrium in absence of heart disease,Object
transthoracic echocardiogram,Subject
right atrium,Object
basal echocardiogram,Subject
right atrium with smoke pattern in absence of heart disease,Object
basal transthoracic echocardiogram,Subject
right atrium with thick smoke pattern in absence of congenital heart disease,Object
basal echocardiogram,Subject
right atrium with smoke pattern in absence of congenital heart disease,Object
transthoracic echocardiogram,Subject
right atrium with smoke pattern,Object
basal echocardiogram,Subject
right atrium in absence of heart disease,Object
basal transthoracic echocardiogram,Subject
right atrium with thick smoke pattern,Object
transthoracic echocardiogram,Subject
right atrium with smoke pattern in absence of congenital heart disease,Object
basal transthoracic echocardiogram,Subject
huge right atrium in absence,Object
basal transthoracic echocardiogram,Subject
right atrium with thick smoke pattern in absence,Object
basal echocardiogram,Subject
right atrium with thick smoke pattern in absence,Object
echocardiogram,Subject
huge right atrium in absence of congenital heart disease,Object
transthoracic echocardiogram,Subject
right atrium in absence of congenital heart disease,Object
basal echocardiogram,Subject
huge right atrium with thick smoke pattern in absence of congenital heart disease,Object
echocardiogram,Subject
right atrium with smoke pattern,Object
transthoracic echocardiogram,Subject
right atrium in absence,Object
echocardiogram,Subject
huge right atrium with smoke pattern in absence of congenital heart disease,Object
basal transthoracic echocardiogram,Subject
huge right atrium with smoke pattern in absence of heart disease,Object
transthoracic echocardiogram,Subject
huge right atrium with smoke pattern,Object
basal echocardiogram,Subject
right atrium with smoke pattern,Object
echocardiogram,Subject
right atrium in absence of congenital heart disease,Object
echocardiogram,Subject
right atrium with smoke pattern in absence of congenital heart disease,Object
basal echocardiogram,Subject
huge right atrium with smoke pattern in absence of heart disease,Object
basal transthoracic echocardiogram,Subject
huge right atrium with thick smoke pattern,Object
echocardiogram,Subject
huge right atrium with thick smoke pattern,Object
basal transthoracic echocardiogram,Subject
huge right atrium with smoke pattern in absence of congenital heart disease,Object
transthoracic echocardiogram,Subject
right atrium with thick smoke pattern in absence of heart disease,Object
basal transthoracic echocardiogram,Subject
right atrium with smoke pattern,Object
echocardiogram,Subject
right atrium in absence of heart disease,Object
basal transthoracic echocardiogram,Subject
right atrium,Object
basal echocardiogram,Subject
right atrium with thick smoke pattern in absence of congenital heart disease,Object
basal transthoracic echocardiogram,Subject
right atrium with smoke pattern in absence of heart disease,Object
basal echocardiogram,Subject
huge right atrium with thick smoke pattern in absence,Object
basal echocardiogram,Subject
huge right atrium with smoke pattern,Object
transthoracic echocardiogram,Subject
huge right atrium with thick smoke pattern in absence,Object
transthoracic echocardiogram,Subject
right atrium with thick smoke pattern in absence of congenital heart disease,Object
echocardiogram,Subject
right atrium,Object
echocardiogram,Subject
huge right atrium with smoke pattern in absence,Object
basal transthoracic echocardiogram,Subject
huge right atrium,Object
huge right atrium,Subject
absence of congenital heart disease,Object
transthoracic echocardiogram,Subject
right atrium with smoke pattern in absence,Object
basal transthoracic echocardiogram,Subject
huge right atrium in absence of heart disease,Object
Magnetic resonance imaging,Subject
initial compression of ventricle,Object
Magnetic resonance imaging,Subject
atriomegaly,Object
resonance imaging,Subject
initial compression,Object
resonance imaging,Subject
initial compression of ventricle,Object
resonance imaging,Subject
right atriomegaly,Object
Magnetic resonance imaging,Subject
initial compression,Object
resonance imaging,Subject
compression of ventricle,Object
resonance imaging,Subject
compression,Object
resonance imaging,Subject
atriomegaly,Object
Magnetic resonance imaging,Subject
right atriomegaly,Object
Magnetic resonance imaging,Subject
compression,Object
Magnetic resonance imaging,Subject
compression of ventricle,Object
patient,Subject
surgical resection,Object
patient,Subject
surgical resection of wall,Object
patient,Subject
surgical resection of right atrial wall,Object
patient,Subject
resection of right wall,Object
leaving,Subject
consistency,Object
leaving,Subject
consistency,Object
patient,Subject
resection of wall,Object
patient,Subject
surgical resection of right wall,Object
leaving,Subject
normal consistency,Object
patient,Subject
resection of right atrial wall,Object
patient,Subject
surgical resection of atrial wall,Object
patient,Subject
resection of atrial wall,Object
patient,Subject
resection,Object
leaving,Subject
normal consistency,Object
resected atrium,Subject
normal wall thickness,Object
atrium,Subject
wall thickness,Object
resected atrium,Subject
wall thickness,Object
atrium,Subject
normal wall thickness,Object
portal perfusion,Subject
portosystemic shunt,Object
perfusion,Subject
portosystemic shunt leading to development,Object
perfusion,Subject
shunt,Object
perfusion,Subject
bypassed,Object
portal perfusion,Subject
bypassed,Object
portal perfusion,Subject
shunt leading,Object
portal perfusion,Subject
portosystemic shunt leading to development of hypertension,Object
portal perfusion,Subject
shunt,Object
perfusion,Subject
shunt leading,Object
portal perfusion,Subject
portosystemic shunt leading to development,Object
perfusion,Subject
portosystemic shunt leading to development of hypertension,Object
portal perfusion,Subject
portosystemic shunt leading to development of portal hypertension,Object
portal perfusion,Subject
shunt leading to development of hypertension,Object
portal perfusion,Subject
shunt leading to development,Object
perfusion,Subject
shunt leading to development,Object
portal perfusion,Subject
portosystemic shunt leading,Object
perfusion,Subject
shunt leading to development of portal hypertension,Object
perfusion,Subject
portosystemic shunt,Object
perfusion,Subject
shunt leading to development of hypertension,Object
perfusion,Subject
portosystemic shunt leading,Object
portal perfusion,Subject
shunt leading to development of portal hypertension,Object
perfusion,Subject
portosystemic shunt leading to development of portal hypertension,Object
absence,Subject
rare,Object
liver cancer,Subject
can associated with CAPVS,Object
liver cancer,Subject
can associated,Object
Natural killer/T-cell lymphoma,Subject
subtype,Object
non-Hodgkin,Subject
lymphoma,Object
Natural killer/T-cell lymphoma,Subject
rare subtype,Object
lymphoma,Subject
rare,Object
killer/T-cell lymphoma,Subject
subtype,Object
killer/T-cell lymphoma,Subject
rare subtype,Object
clinicopathological features,Subject
lymphomas,Object
features,Subject
lymphomas,Object
clinicopathological features,Subject
unique,Object
features,Subject
unique,Object
poor prognosis,Subject
absence of effective treatment,Object
NKTL,Subject
poor prognosis in absence of treatment,Object
NKTL,Subject
prognosis in absence,Object
NKTL,Subject
prognosis in absence of effective treatment,Object
NKTL,Subject
prognosis,Object
NKTL,Subject
aggressive,Object
NKTL,Subject
prognosis in absence of effective treatment,Object
aggressive disease,Subject
poor prognosis in absence of effective treatment,Object
NKTL,Subject
prognosis in absence of treatment,Object
NKTL,Subject
aggressive disease,Object
NKTL,Subject
poor prognosis in absence,Object
NKTL,Subject
prognosis in absence of treatment,Object
NKTL,Subject
poor prognosis in absence of treatment,Object
NKTL,Subject
prognosis,Object
NKTL,Subject
poor prognosis,Object
NKTL,Subject
poor prognosis in absence of effective treatment,Object
NKTL,Subject
prognosis in absence,Object
NKTL,Subject
disease,Object
NKTL,Subject
poor prognosis in absence,Object
NKTL,Subject
poor prognosis,Object
NKTL,Subject
poor prognosis in absence of effective treatment,Object
staging,Subject
appropriate treatment strategy,Object
staging,Subject
prognosis,Object
staging,Subject
treatment strategy,Object
staging,Subject
essential,Object
staging,Subject
accurate prognosis,Object
diagnosis,Subject
essential,Object
Accurate diagnosis,Subject
essential,Object
staging,Subject
treatment strategy of NKTL,Object
staging,Subject
appropriate treatment strategy of NKTL,Object
Modified Checklist,Subject
Toddlers-revised/follow-up,Object
Checklist,Subject
developed,Object
Modified Checklist,Subject
number of cases,Object
Modified Checklist,Subject
developed,Object
Checklist,Subject
number of cases,Object
Modified Checklist,Subject
number,Object
Checklist,Subject
number,Object
aim,Subject
version in Spanish public health system,Object
aim,Subject
Spanish version of M-CHAT-R/F in health system,Object
aim,Subject
Spanish version in health system,Object
aim,Subject
version,Object
aim,Subject
version in public health system,Object
aim,Subject
Spanish version,Object
aim,Subject
Spanish version in Spanish health system,Object
aim,Subject
version of M-CHAT-R/F in public health system,Object
aim,Subject
version of M-CHAT-R/F,Object
aim,Subject
Spanish version of M-CHAT-R/F in Spanish public health system,Object
aim,Subject
Spanish version of M-CHAT-R/F in Spanish health system,Object
aim,Subject
Spanish version of M-CHAT-R/F,Object
aim,Subject
Spanish version in public health system,Object
Spanish version,Subject
Spanish public health system,Object
aim,Subject
version of M-CHAT-R/F in Spanish health system,Object
aim,Subject
Spanish version in Spanish public health system,Object
aim,Subject
version of M-CHAT-R/F in health system,Object
aim,Subject
version in health system,Object
aim,Subject
version of M-CHAT-R/F in Spanish public health system,Object
aim,Subject
version in Spanish health system,Object
aim,Subject
Spanish version of M-CHAT-R/F in public health system,Object
M-CHAT-R/F,Subject
translated,Object
15 children,Subject
ASD,Object
15 children,Subject
autism spectrum disorder,Object
children,Subject
diagnosed,Object
15 children,Subject
39 positive screening cases,Object
children,Subject
39 positive screening cases,Object
15 children,Subject
39 screening cases,Object
children,Subject
Of 39 screening cases diagnosed with autism spectrum disorder,Object
15 children,Subject
Of 39 screening cases diagnosed with autism spectrum disorder,Object
children,Subject
autism spectrum disorder,Object
15 children,Subject
Of 39 positive screening cases diagnosed with autism spectrum disorder,Object
15 children,Subject
diagnosed,Object
children,Subject
Of 39 positive screening cases diagnosed with autism spectrum disorder,Object
children,Subject
ASD,Object
children,Subject
39 screening cases,Object
results,Subject
English,Object
results,Subject
similar,Object
results,Subject
English equivalent,Object
study,Subject
ASD screening program,Object
study,Subject
consider,Object
study,Subject
Spanish National Health System policy makers,Object
study,Subject
universal ASD screening program,Object